IP Library Granted Patent US 8,750,953
Granted Patent B2
US 8,750,953 · App. 12/388,123 · Granted Jun 10, 2014

Methods and systems for alerting practitioners to physiological conditions

Inventors: James Ochs (Seattle, WA); Scott Amundson (Oakland, CA); Keith Batchelder (New York, NY)
Assignee: Covidien LP
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,750,953
App. No.
12/388,123
Granted
Jun 10, 2014
Kind
B2
Abstract

Embodiments of the present disclosure provide systems and methods for monitoring a patient to produce a signal representing a blood oxygen concentration. The signal may be analyzed to determine the presence of one or more sleep apnea events, and an integral of the signal may be calculated if the signal is outside of a set range or threshold. A practitioner may choose to be informed of the presence of sleep apnea events if the blood oxygen concentration is less then a preset limit, if an upper limit has been reached for an integral representing the severity of the oxygen deprivation over time, or anytime sleep apnea events may be present in the signal.

Claims (37)

1. A tangible non-transitory machine-readable medium, comprising:

code configured to cause a processor to analyze a signal to determine a presence of one or more oxygen desaturation patterns, wherein the signal is representative of one or more oxygen saturation values;

code configured to cause the processor to determine a value for an integral of the signal if the signal is outside of a predetermined range or threshold;

code configured to cause the processor to determine whether the signal is indicative of sleep apnea or another type of desaturation event based at least in part upon both the presence of the one or more oxygen desaturation patterns and the value of the integral;

code configured to cause the processor to provide an indication of sleep apnea based at least in part upon the determination that the signal is indicative of sleep apnea; and

code configured to cause the processor to provide an indication of another type of desaturation event based at least in part upon the determination that the signal is indicative of another type of desaturation event.

2. The tangible non-transitory machine readable medium of claim 1 , comprising code configured to cause the processor to calculate the value of the integral of the signal by accumulating a product of time and a difference between the signal and a threshold value.

3. The tangible non-transitory machine readable medium of claim 1 , comprising code configured to cause the processor to determine a presence of a cluster of the one or more oxygen desaturation patterns in the signal.

4. The tangible non-transitory machine readable medium of claim 1 , comprising code configured to cause the processor to provide the indication of sleep apnea as a visual display.

5. The tangible non-transitory machine readable medium of claim 1 , comprising code configured to cause the processor to provide the indication of sleep apnea as an audible alarm signal.

6. A medical device, comprising:

a processor configured to:

analyze a signal to determine a presence of one or more oxygen desaturation patterns;

determine a value for an integral of the signal if the signal is outside of a range or threshold;

provide an indication of sleep apnea based at least in part upon both the presence of the one or more oxygen desaturation patterns and a determination that the value of the integral is greater than a first integral threshold; and

provide an indication of another type of desaturation event based at least in part upon both an absence of the one or more oxygen desaturation patterns and a determination that the value of the integral is greater than a second integral threshold.

7. The medical device of claim 6 , wherein the value of the integral is calculated by accumulating a product of time and a difference between the signal and a threshold value.

8. The medical device of claim 6 , wherein the processor is configured to determine a presence of a cluster of the one or more oxygen desaturation patterns.

9. The medical device of claim 6 , wherein the one or more oxygen desaturation patterns each comprise a desaturation rate and a resaturation rate, and wherein the desaturation rate is slower than the resaturation rate.

10. The medical device of claim 6 , comprising a display, and wherein the indication of sleep apnea comprises a visual display on the medical device.

11. The medical device of claim 6 , wherein the indication of another type of desaturation event comprises an audible alarm signal.

12. The medical device of claim 6 , comprising a treatment device operatively coupled to the processor, and wherein the processor is configured to activate the treatment device when the processor provides the indication of sleep apnea.

13. The medical device of claim 6 , comprising a sensor configured to collect the signal.

14. A system, comprising:

a sensor configured to generate a physiological signal of a patient;

a patient monitor comprising a processor configured to:

receive the physiological signal from the sensor;

analyze the signal to determine a presence of an oxygen desaturation pattern;

determine a value for an integral of the signal if the signal passes a threshold;

provide an indication of sleep apnea based at least in part upon both the presence of the oxygen desaturation pattern and a determination that the value of the integral is greater than a first integral threshold; and

provide an indication of a non-apneic event based at least in part upon both an absence of the oxygen desaturation pattern and a determination that the value of the integral is greater than a second integral threshold.

15. The system of claim 14 , wherein the patient monitor comprises a display, and wherein the processor is configured to cause the display to provide the indication of sleep apnea and the indication of the non-apneic event.

16. The system of claim 14 , wherein the value of the integral is calculated by accumulating a product of time and a difference between the signal and a threshold value.

17. The system of claim 14 , wherein the processor is configured to determine a presence of a cluster of the oxygen desaturation pattern in the signal and to provide an indication of sleep apnea based at least in part upon the presence of the cluster.

18. The system of claim 14 , comprising a mask operatively coupled to the processor, and wherein the processor is configured to increase an air pressure supplied by the mask when the processor provides the indication of sleep apnea.

19. The system of claim 14 , comprising a network interface unit configured to send information comprising the signal, the indication of sleep apnea, the indication of the non-apneic event, or an alarm signal, to a device located on a local area network.

20. The system of claim 14 , wherein the oxygen desaturation pattern comprises a desaturation rate and a resaturation rate, and wherein the desaturation rate is slower than the resaturation rate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2018
From: OCHS, JAMES; AMUNDSON, SCOTT; BATCHELDER, KEITH
To: COVIDIEN LP
Reel/Frame 046749/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029379/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2009
From: OCHS, JAMES; AMUNDSON, SCOTT; BATCHELDER, KEITH
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 022600/0046 →
Continuity (2)
Provisional Application 61066182 · Feb 19, 2008
Related Publication 20090209839A1 · Aug 20, 2009